Remeditex Ventures
North America, Texas, United States, Dallas
Description
Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential.
Investor Profile
Remeditex Ventures has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 29% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Therapeutics, Biotechnology.
Stage Focus
- Series B (47%)
- Series C (24%)
- Series A (18%)
- Post Ipo Equity (6%)
- Series D (6%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Therapeutics
- Biotechnology
- Pharmaceutical
- Medical Device
- Genetics
- Oncology
- Health Diagnostics
- Biopharma
- Developer Platform
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
